[HTML][HTML] Laboratory confirmed vaccine-induced immune thrombotic thrombocytopenia: Retrospective analysis of reported cases after vaccination with ChAdOx-1 nCoV …
T Thiele, K Weisser, L Schönborn, MB Funk… - The Lancet Regional …, 2022 - thelancet.com
Background Vaccine-induced immune thrombotic thrombocytopenia (VITT) is a severe
adverse event of SARS-CoV-2 vaccination. We describe the characteristics of patients …
adverse event of SARS-CoV-2 vaccination. We describe the characteristics of patients …
[PDF][PDF] Laboratory confirmed vaccine-induced immune thrombotic thrombocytopenia: Retrospective analysis of reported cases after vaccination with ChAdOx-1 nCoV …
T Thiele, K Weisser, L Schonborn, MB Funk… - …, 2022 - covid19.ccg.unam.mx
Background Vaccine-induced immune thrombotic thrombocytopenia (VITT) is a severe
adverse event of SARS-CoV-2 vaccination. We describe the characteristics of patients …
adverse event of SARS-CoV-2 vaccination. We describe the characteristics of patients …
Laboratory confirmed vaccine-induced immune thrombotic thrombocytopenia: Retrospective analysis of reported cases after vaccination with ChAdOx-1 nCoV-19 in …
T Thiele, K Weisser, L Schönborn… - The Lancet …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Vaccine-induced immune thrombotic thrombocytopenia (VITT) is a severe
adverse event of SARS-CoV-2 vaccination. We describe the characteristics of patients …
adverse event of SARS-CoV-2 vaccination. We describe the characteristics of patients …
[HTML][HTML] Laboratory confirmed vaccine-induced immune thrombotic thrombocytopenia: Retrospective analysis of reported cases after vaccination with ChAdOx-1 nCoV …
T Thiele, K Weisser, L Schönborn… - The Lancet Regional …, 2022 - ncbi.nlm.nih.gov
Background Vaccine-induced immune thrombotic thrombocytopenia (VITT) is a severe
adverse event of SARS-CoV-2 vaccination. We describe the characteristics of patients …
adverse event of SARS-CoV-2 vaccination. We describe the characteristics of patients …
[HTML][HTML] Laboratory confirmed vaccine-induced immune thrombotic thrombocytopenia: Retrospective analysis of reported cases after vaccination with ChAdOx-1 nCoV …
T Thiele, K Weisser, L Schönborn, MB Funk… - The Lancet Regional …, 2022 - Elsevier
Background Vaccine-induced immune thrombotic thrombocytopenia (VITT) is a severe
adverse event of SARS-CoV-2 vaccination. We describe the characteristics of patients …
adverse event of SARS-CoV-2 vaccination. We describe the characteristics of patients …
Laboratory confirmed vaccine-induced immune thrombotic thrombocytopenia: Retrospective analysis of reported cases after vaccination with ChAdOx-1 nCoV-19 in …
T Thiele, K Weisser, L Schönborn, MB Funk… - The Lancet Regional …, 2021 - europepmc.org
Background Vaccine-induced immune thrombotic thrombocytopenia (VITT) is a severe
adverse event of SARS-CoV-2 vaccination. We describe the characteristics of patients …
adverse event of SARS-CoV-2 vaccination. We describe the characteristics of patients …
Laboratory confirmed vaccine-induced immune thrombotic thrombocytopenia: Retrospective analysis of reported cases after vaccination with ChAdOx-1 nCoV-19 in …
T Thiele, K Weisser, L Schönborn, MB Funk… - The Lancet Regional …, 2021 - europepmc.org
Background Vaccine-induced immune thrombotic thrombocytopenia (VITT) is a severe
adverse event of SARS-CoV-2 vaccination. We describe the characteristics of patients …
adverse event of SARS-CoV-2 vaccination. We describe the characteristics of patients …